Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria

Hironori Ochi, Kouji Joko(Matsuyama Red Cross Hospital), Tomoyuki Yokota(The University of Tokyo), Yoichi Hiasa(Ehime University Hospital), Atsushi Hiraoka(Ehime Prefectural Central Hospital), Michiko Amano(Matsuyama Red Cross Hospital), Masashi Hirooka(Ehime University), Kojiro Michitaka(Ehime Prefectural Central Hospital), Masanori Abe(Ehime University), Yohei Koizumi(Ehime University), Yoshio Tokumoto(Ehime University), Takao Watanabe(Miyoshi Kasei (Japan)), Nobuaki Azemoto(Matsuyama Red Cross Hospital), Osamu Yoshida(Ehime University Hospital), Toshie Mashiba(Jikei University School of Medicine)
Journal of Gastroenterology
December 5, 2020
Cited by 45


Related Papers